Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Genes Dev ; 28(19): 2134-50, 2014 Oct 01.
Article in English | MEDLINE | ID: mdl-25274726

ABSTRACT

During the process of tumor progression, cancer cells can produce the requisite growth- and invasion-promoting factors and can also rely on noncancerous cells in the tumor microenvironment as an alternative, cell-extrinsic source. However, whether the cellular source influences the function of such tumor-promoting factors remains an open question. Here, we examined the roles of the cathepsin Z (CtsZ) protease, which is provided by both cancer cells and macrophages in pancreatic neuroendocrine tumors in humans and mice. We found that tumor proliferation was exclusively regulated by cancer cell-intrinsic functions of CtsZ, whereas tumor invasion required contributions from both macrophages and cancer cells. Interestingly, several of the tumor-promoting functions of CtsZ were not dependent on its described catalytic activity but instead were mediated via the Arg-Gly-Asp (RGD) motif in the enzyme prodomain, which regulated interactions with integrins and the extracellular matrix. Together, these results underscore the complexity of interactions within the tumor microenvironment and indicate that cellular source can indeed impact molecular function.


Subject(s)
Cathepsin Z/metabolism , Extracellular Matrix/metabolism , Macrophages/enzymology , Neoplasms/enzymology , Neoplasms/physiopathology , Animals , Cell Line, Tumor , Integrins/metabolism , Mice, Inbred C57BL , Neoplasm Invasiveness/physiopathology
2.
Genes Dev ; 24(3): 241-55, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-20080943

ABSTRACT

Innate immune cells can constitute a substantial proportion of the cells within the tumor microenvironment and have been associated with tumor malignancy in patients and animal models of cancer; however, the mechanisms by which they modulate cancer progression are incompletely understood. Here, we show that high levels of cathepsin protease activity are induced in the majority of macrophages in the microenvironment of pancreatic islet cancers, mammary tumors, and lung metastases during malignant progression. We further show that tumor-associated macrophage (TAM)-supplied cathepsins B and S are critical for promoting pancreatic tumor growth, angiogenesis, and invasion in vivo, and markedly enhance the invasiveness of cancer cells in culture. Finally, we demonstrate that interleukin-4 (IL-4) is responsible for inducing cathepsin activity in macrophages in vitro and in vivo. Together, these data establish IL-4 as an important regulator, and cathepsin proteases as critical mediators, of the cancer-promoting functions of TAMs.


Subject(s)
Cathepsins/metabolism , Interleukin-4/metabolism , Macrophages/enzymology , Neoplasm Invasiveness , Neoplasms/enzymology , Animals , Biomarkers, Tumor/metabolism , Cell Line, Tumor , Female , Lung Neoplasms/pathology , Macrophages/metabolism , Mammary Neoplasms, Experimental , Mice , Mice, Transgenic , Neoplasms/pathology , Neovascularization, Pathologic/enzymology , Neovascularization, Pathologic/pathology , Pancreatic Neoplasms/pathology
3.
PLoS One ; 8(5): e64472, 2013.
Article in English | MEDLINE | ID: mdl-23691228

ABSTRACT

Pancreatic neuroendocrine tumors (PanNETs) are a relatively rare but clinically challenging tumor type. In particular, high grade, poorly-differentiated PanNETs have the worst patient prognosis, and the underlying mechanisms of disease are poorly understood. In this study we have identified and characterized a previously undescribed class of poorly differentiated PanNETs in the RIP1-Tag2 mouse model. We found that while the majority of tumors in the RIP1-Tag2 model are well-differentiated insulinomas, a subset of tumors had lost multiple markers of beta-cell differentiation and were highly invasive, leading us to term them poorly differentiated invasive carcinomas (PDICs). In addition, we found that these tumors exhibited a high mitotic index, resembling poorly differentiated (PD)-PanNETs in human patients. Interestingly, we identified expression of Id1, an inhibitor of DNA binding gene, and a regulator of differentiation, specifically in PDIC tumor cells by histological analysis. The identification of PDICs in this mouse model provides a unique opportunity to study the pathology and molecular characteristics of PD-PanNETs.


Subject(s)
Carcinogenesis , Carcinoma, Neuroendocrine/pathology , Disease Models, Animal , Pancreatic Neoplasms/pathology , Animals , Biomarkers, Tumor/metabolism , Carcinoma, Neuroendocrine/genetics , Carcinoma, Neuroendocrine/metabolism , Gene Expression Regulation, Neoplastic , Inhibitor of Differentiation Protein 1/genetics , Mice , Mitosis , Neoplasm Invasiveness , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/metabolism
4.
Science ; 322(5902): 703-9, 2008 Oct 31.
Article in English | MEDLINE | ID: mdl-18974345

ABSTRACT

Aneuploidy, an incorrect number of chromosomes, is the leading cause of miscarriages and mental retardation in humans and is a hallmark of cancer. We examined the effects of aneuploidy on primary mouse cells by generating a series of cell lines that carry an extra copy of one of four mouse chromosomes. In all four trisomic lines, proliferation was impaired and metabolic properties were altered. Immortalization, the acquisition of the ability to proliferate indefinitely, was also affected by the presence of an additional copy of certain chromosomes. Our data indicate that aneuploidy decreases not only organismal but also cellular fitness and elicits traits that are shared between different aneuploid cells.


Subject(s)
Aneuploidy , Cell Proliferation , Gene Expression , Glucose/metabolism , Glutamine/metabolism , Trisomy , Animals , Cell Cycle , Cell Line , Cell Size , Cell Transformation, Neoplastic , Cellular Senescence , Culture Media , Embryo, Mammalian , Fibroblasts , Gene Dosage , Genomic Instability , Metabolic Networks and Pathways , Mice , Serial Passage , Translocation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL